Rancho Cordova Medicaid providers submitted $55,070 in claims for services within the Drugs Administered Other than Oral Method category in 2024, according to the U.S. Department of Health and Human Services Medicaid Provider Spending database. This represents a 58% rise compared to 2023, when $34,859 was billed for the same category.
Medicaid is a state-managed public health insurance program funded jointly by federal and state governments. It provides coverage for low-income individuals and families, seniors, children, and people with disabilities, making it a major segment of the U.S. health care system.
Because Medicaid draws on taxpayer funds, fluctuations in local billing indicate how public health resources are distributed in local communities.
The “Drugs Administered Other than Oral Method” group comprises Medicaid services identified by care type using standardized HCPCS and CPT coding. For this review, each code was assigned to one service category following consistent code prefixes and number ranges, so related services could be tracked without duplication, ensuring accurate historical rankings.
While spending rose in several service groups, Drugs Administered Other than Oral Method ranked sixth for total Medicaid payments in Rancho Cordova in 2024.
Across California, Drugs Administered Other than Oral Method ranked 14th among service categories by Medicaid payments during 2024.
Looking at the five-year period ending in 2024, Medicaid billing for the Drugs Administered Other than Oral Method category in Rancho Cordova rose by $53,352, up 3,104.6%. This growth included accelerated year-to-year increases, especially in 2022 and 2023.
Payment for care in this category was not broadly distributed: in 2024, claims were concentrated in certain local ZIP codes, with ZIP code 95670 accounting for the full $55,070. This single area represented 100% of Medicaid payments for this category in Rancho Cordova that year.
Most Medicaid payments in this service grouping were tied to a select group of billing codes.
In perspective, the 58% increase in Rancho Cordova Medicaid payments for Drugs Administered Other than Oral Method from 2023 to 2024 was nearly double the 31.6% increase observed for all Medicaid claim categories in the city during that span.
According to the Centers for Medicare & Medicaid Services, nationwide Medicaid spending by federal and state sources reached about $871.7 billion in fiscal year 2023, making up roughly 18% of all national health spending. This was a sharp increase compared with $613.5 billion in 2019, before the COVID-19 pandemic.
This increase equals growth of about 40% in just a few years, primarily due to expanded program enrollment and greater service usage during and after the pandemic.
Recent federal budget measures under the Trump administration have included major proposals to reduce federal Medicaid funding and change program structure. For instance, the “One Big Beautiful Bill Act,” enacted in 2025, is expected to reduce federal Medicaid funding by over $1 trillion in the next decade while introducing work requirements and increased cost-sharing that may reduce access and funding for certain groups. These policies could shift more responsibility to state governments and limit expansion of federal Medicaid support, even as program demand continues.
| Year | Total Medicaid Payments | % Change From Previous Year |
|---|---|---|
| 2020 | $1,718 | -62.2% |
| 2021 | $442 | -74.3% |
| 2022 | $9,896 | 2137.6% |
| 2023 | $34,859 | 252.2% |
| 2024 | $55,070 | 58% |
| Rank | Category | Medicaid Payments | Share of City Total |
|---|---|---|---|
| 1 | Medicine Services and Procedures | $946,852 | 44.9% |
| 2 | Dental Services | $359,678 | 17% |
| 3 | Surgery | $317,539 | 15.1% |
| 4 | Procedures / Professional Services | $243,215 | 11.5% |
| 5 | National Codes Established for State Medicaid Agencies | $74,285 | 3.5% |
| 6 | Drugs Administered Other than Oral Method | $55,070 | 2.6% |
| 7 | Evaluation and Management | $50,745 | 2.4% |
| 8 | Vision Services | $37,556 | 1.8% |
| 9 | Alcohol and Drug Abuse Treatment | $7,690 | 0.4% |
| 10 | Durable Medical Equipment | $7,508 | 0.4% |
| 11 | Radiology Procedures | $4,892 | 0.2% |
| 12 | Chemotherapy Drugs | $3,921 | 0.2% |
| 13 | Anesthesia | $403 | <0.1% |
| 14 | Medical And Surgical Supplies | $225 | <0.1% |
| 15 | Pathology and Laboratory Procedures | $0 | <0.1% |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| J0178 | Aflibercept injection | $50,778 | 11 |
| J2777 | Inj, faricimab-svoa, 0.1mg | $4,291 | 1 |
| J0887 | Epoetin beta esrd use | $0 | 6 |
| J1644 | Inj heparin sodium per 1000u | $0 | 5 |
| J1756 | Iron sucrose injection | $0 | 6 |
Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.
Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.
